Details of the new rules for COVID-19 vaccine approvals were also outlined in an article published by The New England Journal ...

Only adults 65 and older or people with another health problem that puts them at higher risk will be able to get the shots ...

The US Food and Drug Administration is changing the way it approves Covid-19 vaccines for Americans, a move that may limit ...

The VRBPAC meeting comes the week after the World Health Organization (WHO) recommended that members consider using ...

L+M Development nabbed a $36.9M mortgage from Lument for its 91-unit rental project at 235 Central Park N. in Harlem, ...

The change marks a shift in the Food and Drug Administration’s policy on approving COVID-19 vaccines, which the new ...

COVID-19 shots for healthy younger adults and children will no longer be routinely approved under a major new policy shift unveiled Tuesday by the Trump administration.

Jeffrey Casberg, M.S., vice president of clinical pharmacy at IPD Analytics, shared his insights on the results of Managed Healthcare Executive’s annual Pharmacy Survey in this part-two interview of a ...

The pharma giant entered an exclusive agreement with the Chinese biotech to gain rights to a cancer bispecific drug candidate.

Top officials in the Trump administration on Tuesday announced they will limit the approval of new COVID-19 vaccines to adults over 65 and people who are high risk. The move is a significant shift ...

The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.